| Literature DB >> 32574446 |
.
Abstract
There have been numerous recent inquiries regarding use of hyperbaric oxygen (HBO2) for patients with COVID-19. Questions have been raised pertinent to two possible mechanisms for HBO2 in this clinical context. The UHMS Hyperbaric Oxygen Therapy Committee, UHMS Executive Committee, with collaborative input from multiple senior UHMS members and researchers have drafted this position statement. Copyright© Undersea and Hyperbaric Medical Society.Entities:
Keywords: ARDS ; COVID-19 ; SARS-CoV-2 ; UHMS position ; hyperbaric oxygen therapy ; hyperbaric treatment of COVID-19 ; hypoxemia ; hypoxia ; novel corona virus ; pneumonia ; pulmonary inflammation ; viral infections
Mesh：
Year: 2020 PMID： 32574446
Source DB: PubMed Journal: Undersea Hyperb Med ISSN： 1066-2936 Impact factor: 0.698